Considering the link between elevated Noxa1 expression and unfavorable outcomes in colorectal cancer patients, along with its loss-of-function mutations, we performed a comprehensive analysis to confirm its role as a standalone prognostic marker. This evidence concerns the gene NOXA1 and colorectal cancer.